Search Results - "Miller, Karvelisse"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Radiation protection and mitigation potential of phenylbutyrate: delivered via oral administration by Miller, Alexandra C., Rivas, Rafael, McMahon, Robert, Miller, Karvelisse, Tesoro, Leonard, Villa, Vilmar, Yanushkevich, Daminik, Lison, Paul

    Published in International journal of radiation biology (02-09-2017)
    “…Purpose: Phenylbutyrate (PB), a histone deacetylase inhibitor (HDACi) has demonstrated radiation protection in both in vitro and in vivo models. Studies…”
    Get full text
    Journal Article
  2. 2

    Abstract 3590: Depleted uranium-induced leukemia: Epigenetic and genetic changes by Miller, Alexandra C., Clancy, Hailey, Kluz, Thomas, Cohen, Stuart, Rivas, Rafael, Miller, Karvelisse, Costa, Max

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Epigenetic and genetic changes are associated with leukemia development. Depleted uranium is used in military missions and U.S. military personnel…”
    Get full text
    Journal Article
  3. 3

    Abstract 4717: The anti-leukemic efficacy of the histone deacetylase inhibitor phenylbutyrate (PB): Reversal of epigenetic inactivation of WNT signalling pathway by PB by Miller, Alexandra C., Cohen, Stuart, Rivas, Rafael, Miller, Karvelisse, Lison, Paul

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract The histone deacetylase inhibitor (HDAC), phenylbutyrate (PB), is a novel antitumor agent. PB has shown anti-cancer efficacy in clinical trials and in…”
    Get full text
    Journal Article